< 110 > Chungbuk National University Industry - Academic Cooperation Foundation < 120 > PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OF INFLAMMATORY SKIN DISEASES COMPRISING INTERLEUKIN - 32 PROTEIN AS AN ACTIVE INGREDIENT < 130 > DP - 2019 - 0049 - KR < 160 > 26 < 170 > KoPatentIn 3 . 0 < 210 > 1 < 211 > 22 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > 18 S forward < 400 > 1 aggaattgac ggaagggcac ca 22 < 210 > 2 < 211 > 21 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > 18 S reverse < 400 > 2 gtgcagcccc ggacatctaa g 21 < 210 > 3 < 211 > 21 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > TSLP forward < 400 > 3 acggatgggg ctaacttaca a 21 < 210 > 4 < 211 > 21 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > TSLP reverse < 400 > 4 agtcctcgat ttgctcgaac t 21 < 210 > 5 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > IL - 4 forward < 400 > 5 ggtctcaacc cccagctagt 20 < 210 > 6 < 211 > 23 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > IL - 4 reverse < 400 > 6 gccgatgatc tctctcaagt gat 23 < 210 > 7 < 211 > 19 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > IL - 13 forward < 400 > 7 cctggctctt gcttgcctt 19 < 210 > 8 < 211 > 21 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > IL - 13 reverse < 400 > 8 ggtcttgtgt gatgttgctc a 21 < 210 > 9 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > TARC forward < 400 > 9 gtcttgaagc ctcctcaccc 20 < 210 > 10 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > TARC reverse < 400 > 10 ggatctccct cactgtggct 20 < 210 > 11 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > MDC forward < 400 > 11 gttgtcctcg tcctccttgc 20 < 210 > 12 < 211 > 24 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > MDC reverse < 400 > 12 ggagtctgag gtccagtaga agtg 24 < 210 > 13 < 211 > 22 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > TNF - alpha forward < 400 > 13 cctctctcta atcagccctc tg 22 < 210 > 14 < 211 > 21 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > TNF - alpha reverse < 400 > 14 gaggacctgg gagtagatga g 21 < 210 > 15 < 211 > 18 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > IL - 1 beta forward < 400 > 15 cgaggcacaa ggcacaac 18 < 210 > 16 < 211 > 23 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > IL - 1 beta reverse < 400 > 16 gccactgtaa taagccatca ttt 23 < 210 > 17 < 211 > 21 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > IL - 5 forward < 400 > 17 caccgagctc tgttgacaag c 21 < 210 > 18 < 211 > 23 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > IL - 5 reverse < 400 > 18 gagtagggac aggaagcctc atc 23 < 210 > 19 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > IL - 31 forward < 400 > 19 cacacaggaa caacgaagcc 20 < 210 > 20 < 211 > 19 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > IL - 31 reverse < 400 > 20 cgatattggg gcaccgaag 19 < 210 > 21 < 211 > 21 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > IL - 33 forward < 400 > 21 tccaactcca agatttcccc g 21 < 210 > 22 < 211 > 21 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > IL - 33 reverse < 400 > 22 catgcagtag acatggcaga a 21 < 210 > 23 < 211 > 23 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > IL - 6 forward < 400 > 23 gaggatacca ctcccaacag acc 23 < 210 > 24 < 211 > 24 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > IL - 6 reverse < 400 > 24 aagtgcatca tcgttgttca taca 24 < 210 > 25 < 211 > 21 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > IL - 17 A forward < 400 > 25 tttaactccc ttggcgcaaa a 21 < 210 > 26 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > IL - 17 A reverse < 400 > 26 ctttccctcc gcattgacac 20